Key result
71% of systematic reviews in high-impact cardiology journals have low or critically low AMSTAR scores.
Why the study?
Systematic reviews are increasingly used as sources of evidence in clinical cardiology guidelines, prompting an assessment of their quality in high impact cardiology journals.
Cross-Sectional (n=352)
There are widespread methodological gaps in systematic reviews published in high-impact cardiology journals, with 71% demonstrating low or critically low quality scores.
Clinicians should interpret cardiology systematic reviews with caution; confirms widespread methodological shortcomings and extends the need for stricter standards.
Objective: Systematic reviews are increasingly used as sources of evidence in clinical cardiology guidelines. In the present study, we aimed to assess the quality of published systematic reviews in high impact cardiology journals. Methods: We searched PubMed for systematic reviews published between 2010 and 2019 in five general cardiology journals with the highest impact factor (according to Clarivate Analytics 2019). We extracted data on eligibility criteria, methodological characteristics, bias assessments, and sources of funding. Further, we assessed the quality of retrieved reviews using the AMSTAR tool. Results: A total of 352 systematic reviews were assessed. The AMSTAR quality score was low or critically low in 71% (95% CI: 65.7–75.4) of the assessed reviews. Sixty-four reviews (18.2%, 95% CI: 14.5–22.6) registered/published their protocol. Only 221 reviews (62.8%, 95% CI: 57.6–67.7) reported adherence to the EQUATOR checklists, 208 reviews (58.4%, 95% CI: 53.9–64.1) assessed the risk of bias in the included studies, and 177 reviews (52.3%, 95% CI: 45.1–55.5) assessed the risk of publication bias in their primary outcome analysis. The primary outcome was statistically significant in 274 (79.6%, 95% CI: 75.1–83.6) and had statistical heterogeneity in 167 (48.5%, 95% CI: 43.3–53.8) reviews. The use and sources of external funding was not disclosed in 87 reviews (24.7%, 95% CI: 20.5–29.5). Data analysis showed that the existence of publication bias was significantly associated with statistical heterogeneity of the primary outcome and that complex design, larger sample size, and higher AMSTAR quality score were associated with higher citation metrics. Conclusion: Our analysis uncovered widespread gaps in conducting and reporting systematic reviews in cardiology. These findings highlight the importance of rigorous editorial and peer review policies in systematic review publishing, as well as education of the investigators and clinicians on the synthesis and interpretation of evidence.
No takes yet. Share an insight, caveat, or question.
Abushouk et al. (2021) conducted a cross-sectional in Systematic reviews in cardiology (n=352). Quality assessment (AMSTAR tool) was evaluated on Low or critically low AMSTAR quality score (95% CI 65.7-75.4). Quality assessment of 352 systematic reviews in high-impact cardiology journals revealed that 71% (95% CI: 65.7-75.4) had a low or critically low AMSTAR quality score.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: